Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease

Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease

(2014) Marta Olivares et al.   BRITISH JOURNAL OF NUTRITION

Clinical Utility of Celiac Disease-Associated HLA Testing

(2014) Kumar Pallav et al.   DIGESTIVE DISEASES AND SCIENCES

Capability of the Two Microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to Colonize the Intestinal Microbiota of Children

(2014) Luca Mogna et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Celiac Disease Treatment

(2014) Markku Mäki   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Bifidobacterium breve Attenuates Murine Dextran Sodium Sulfate-Induced Colitis and Increases Regulatory T Cell Responses

(2014) Bin Zheng et al.   PLoS One

Duodenal-Mucosal Bacteria Associated with Celiac Disease in Children

(2013) Ester Sánchez et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Exploratory, Randomized, Double-blind, Placebo-controlled Study on the Effects of Bifidobacterium infantis Natren Life Start Strain Super Strain in Active Celiac Disease

(2013) Edgardo Smecuol et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Celiac Disease and Autoimmune-Associated Conditions

(2013) Eugenia Lauret et al.   Biomed Research International

Persistent Duodenal Intraepithelial Lymphocytosis Despite a Long-Term Strict Gluten-Free Diet in Celiac Disease

(2012) Ilus Tuire et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Two faces of microbiota in inflammatory and autoimmune diseases: triggers and drugs

(2012) Miloslav Kverka et al.   APMIS

Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns

(2012) Irene Aloisio et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet

(2012) Christopher S. McAllister et al.   Seminars in Immunopathology

Probiotic Bifidobacterium breve Induces IL-10-Producing Tr1 Cells in the Colon

(2012) Seong Gyu Jeon et al.   PLoS Pathogens

Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization

(2011) Raffaella Di Cagno et al.   BMC MICROBIOLOGY

Novel therapies for coeliac disease

(2011) L. M. Sollid et al.   JOURNAL OF INTERNAL MEDICINE

European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease

(2011) S. Husby et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Distinct Bifidobacterium strains drive different immune responses in vitro

(2010) Patricia López et al.   INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity

(2009) Rossana D’Arienzo et al.   CYTOKINE

Serum cytokine elevations in celiac disease: Association with disease presentation

(2009) John Sanil Manavalan et al.   HUMAN IMMUNOLOGY

Pivotal Advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease

(2009) G. De Palma et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Complications in Celiac Disease Under Gluten-Free Diet

(2008) Antonio Tursi et al.   DIGESTIVE DISEASES AND SCIENCES

Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease

(2008) M C Collado et al.   JOURNAL OF CLINICAL PATHOLOGY

Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients

(2008) Marcela Medina et al.   Journal of Inflammation-London